This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,453 Years Active: 2002
Title: Michel Chrétien: Pioneer in Pro-Protein Converting Enzymes
Introduction
Michel Chrétien is a prominent inventor based in Montréal, Canada, known for his significant contributions to the field of biochemistry. With a focus on human pro-protein converting enzymes, Chrétien's work has implications in vascular health and potential therapeutic applications.
Latest Patents
Michel Chrétien holds one notable patent: the Pro-protein converting enzyme. This invention relates to the cloning of human pro-protein converting enzyme 5 (PC5) cDNA, which was isolated from human adrenal gland messenger RNA. The patent further details a method for reducing restenosis at an injured vascular site by delivering antisense nucleic acid to suppress the expression of human PC5.
Career Highlights
Throughout his career, Michel Chrétien has made significant strides in the understanding of enzyme functions and their roles in human health. His innovative approach has opened new avenues for medical research, particularly in vascular treatments.
Collaborations
Christian has collaborated with notable researchers such as Robert Day and Nabil G Seidah. These partnerships underscore the collaborative nature of scientific research and the shared goal of advancing knowledge in biochemistry.
Conclusion
Michel Chrétien's contributions to the field through his patent and collaboration with esteemed colleagues reflect his commitment to innovation and the advancement of medical science. His work on pro-protein converting enzymes continues to have a profound impact on research and potential therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile